Scholtz & Company LLC purchased a new stake in shares of Novonix Limited (NASDAQ:NVX – Get Rating) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 17,185 shares of the company's stock, valued at approximately $328,000.

Novonix Trading Up 10.9 %

Shares of Novonix stock opened at $7.22 on Monday. The company has a debt-to-equity ratio of 0.16, a quick ratio of 20.32 and a current ratio of 20.56. Novonix Limited has a 12-month low of $5.46 and a 12-month high of $24.00. The firm's 50 day simple moving average is $7.00 and its two-hundred day simple moving average is $11.06.

Novonix Profile

(Get Rating)

See Also

• Get a free copy of the StockNews.com research report on Novonix (NVX)
• 3 Biotech Stocks Gaining Momentum
• Can Electronic Arts Buck the Downturn in Videogaming?
• Dollar General is the Big Fish in Little Ponds Across the U.S.
• Here's Why the CPI Report will Dictate the Market Bottom
• MarketBeat: Week in Review 9/5 – 9/9

Receive News & Ratings for Novonix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novonix and related companies with MarketBeat.com's FREE daily email newsletter.